Clinical Trial Update: Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) [Phase 3]

View source ↗

Summary

Phase III trial comparing adjuvant high-dose cyclophosphamide plus doxorubicin (AC) versus sequential doxorubicin followed by cyclophosphamide (A-C) in high-ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cyclophosphamide (Cytoxan) (cyclophosphamide)
• Doxorubicin (Adriamycin) (doxorubicin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: High Risk, Breast Cancer | Phase 3 | Status: COMPLETED